EVG.L Share News (EVG)

WINNERS & LOSERS SUMMARY: Gold, Dollar Exposure Rewarded Post-Brexit

Evgen Pharma Pleased With "Significant Progress" Since AIM Listing

Evgen Pharma Doses First Patients In Phase 2 SFX-01 Trial For Stroke

Evgen Pharma Gets Approvals To Begin Phase II SFX-01 Trial

CORRECT: DIRECTOR DEALINGS: Evgen Pharma Directors Buy 136,000 Shares

Berkeley Group non-exec picks up first shares

(ShareCast News) - First Derivatives non-executive director David Anderson offloaded 5,000 shares in the software and consulting firm at 1,541p each. The sale brought his interest in the company down to 120,000 shares, or 0.5% of the issued share capital. Elsewhere, Berkeley Group non-executive dir

DIRECTOR DEALINGS: Evgen Pharma Directors Bought 136,000 Shares

Evgen appoints new Chief Medical Officer

(ShareCast News) - Evgen Pharma announced the appointment of a new Chief Medical Officer on Monday. The AIM-listed clinical stage drug development company, focused on the treatment of cancer and neurological conditions, said Dr Hamina Patel would be appointed to the post. Dr Patel was described by

Evgen Says "Very Encouraged" By SFX-01 Development In Maiden Results

BROKER RATINGS SUMMARY: OneSavings Upped To Buy, Aldermore Cut To Hold

Evgen Pharma Buys Licensing Rights For Range Of Compounds In Spain

Evgen Pharma Joins AIM With GBP7.0 Million Raised In IPO (ALLIPO)

London close: Stocks dive on euro worries

The volatility continued heading into the weekend and stocks were nursing hefty losses at the close of play. The resignation of European Central Bank official Juergen Stark brought the Eurozone crisis into focus. Stark, a German, like many of his compatriots is unhappy about the Bank's policy of b

Broker tips: Home Retail, Premier Farnell, Evolution

Singer Capital Markets has slashed its target price for FTSE 250 retailer Home Retail Group by 29%, after the group's first half results showed continued tough trading at Argos and a challenging second quarter for Homebase. "Whilst not as bad as feared the continued weakness of trade at Argos and o

Broker snap: Peel Hunt ups target for Evolution after Investec offer

Following Investec's recommended offer for Evolution, Peel Hunt has raised its target price on the investment banking and stockbroking firm from 86p to 100p to reflect the offer price. Investec, the FTSE 100 South African banking titan, announced on Friday morning that it has made a recommended off